Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells. We investigated the role of the hematopoietic cytokine erythropoietin as an angiogenic factor that modulates tumor progression.Fluore...
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Public Library of Science (PLoS)
2007-06-01
|
| Edice: | PLoS ONE |
| On-line přístup: | http://europepmc.org/articles/PMC1891087?pdf=render |